Agios Pharmaceuticals (AGIO) Current Taxes (2012 - 2025)

Agios Pharmaceuticals (AGIO) reported Current Taxes of $683000.0 for Q1 2025, down 21.58% quarter-over-quarter from $871000.0 in Q4 2024.

Agios Pharmaceuticals (AGIO) Current Taxes (2012 - 2025) Analysis & Trends

Agios Pharmaceuticals has reported Current Taxes for 5 years, with the latest figure at $683000.0 in Q1 2025.

For the quarter ending Q1 2025, Current Taxes changed N/A year-over-year to $683000.0; the trailing twelve-month figure through Mar 2025 stood at $683000.0 (changed N/A YoY), and the FY2024 full-year result was $871000.0, changed N/A from the prior year.
Current Taxes for Q1 2025 stood at $683000.0, down from $871000.0 in the prior quarter.
The five-year high for Current Taxes was $52.7 million in Q3 2024, with the low at $683000.0 in Q1 2025.
Historically, Current Taxes has averaged $13.8 million across 3 years, with a median of $7.6 million in 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	10,460.56
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	19.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Agios Pharmaceuticals	2.01 Bn	2.01 Bn	19.43 Mn	-

Download Data